BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 22, 2003
View Archived Issues
Good safety profile described for the antiobesity drug AOD-9604 in humans
Read More
Weight loss reported with Axokine in obese patients with type 2 diabetes
Read More
Potential role for L-arginine in acute stroke associated with MELAS
Read More
PARG inhibitor effective in reducing brain damage caused by ischemia/reperfusion
Read More
Meiji Seika patent covers novel antibacterial macrolides
Read More
Boehringer Ingelheim claims new CGRP antagonists for migraine and other uses
Read More
New FTase inhibitors prepared and tested by scientists at Servier
Read More
Spotlight on insulin, insulin analogues and insulin formulations
Read More
Amidine-based antifungal agents newly developed at Toyama
Read More
Eisai claims new JNK3 inhibitors and their use in neurodegenerative disorders
Read More
Novel prostanoid EP2 receptor ligands reported by Ono
Read More
Merck KGaA describes new NMDA antagonists and their use
Read More
Broad spectrum of activity described in vivo for S-3578, a new cephalosporin
Read More
Neuroprotective effects described for D-JNKI-1 in an experimental ischemia model
Read More
Boston Scientific and Corautus enter cardiovascular gene therapy strategic alliance
Read More
Cangene signs SARS R&D contract with NIAID
Read More
Xyotax dose amended in STELLAR 4 trial
Read More
Debiopharm plans phase II trial of ZT-1 for Alzheimer's disease
Read More
Lexiva, the only protease inhibitor offering flexible dosing, approved in U.S.
Read More
Paxil CR approved for social anxiety disorder
Read More
Nonapprovable letter for MT-300
Read More
Adderall XR receives approvable letter for use in adults
Read More
Global agreement reached by Roche and Ipsen for GLP-1 analogue
Read More
Novartis receives approvable letter for Certican
Read More
Major codevelopment agreement between Pfizer and Organon for psychotropic compound
Read More
Novel once-daily basal insulin cleared for marketing in Japan
Read More
Beneficial effects of rifaximin in Crohn's disease
Read More
